4-(acetylamino)benzeneacetic acid (Actarit)

10/01/2021 - "Actarit is widely regarded as a safe and effective drug for the treatment of rheumatoid arthritis. "
01/01/1999 - "Actarit (4-acetylaminophenylacetic acid), developed in Japan, has been shown to be effective for suppressing disease activity of rheumatoid arthritis (RA). "
11/19/2020 - "Among the other 25 targets predicted for actarit, RORγ (RAR-related orphan receptor-gamma) is promising in that it is strongly related to actarit's indication, rheumatoid arthritis (RA). "
06/01/2002 - "Twenty patients with elderly rheumatoid arthritis were enrolled on a 48-week course of actarit (300 mg/day). "
06/01/2002 - "Usefulness of actarit in elderly rheumatoid arthritis."

03/20/2008 - "The goal of this study was to design passive targeting nanoparticles which could improve therapeutic efficacy and reduce side-effects such as nephrotoxicity and gastrointestinal disorders commonly associated with oral formulations of actarit. "

05/01/1998 - "Actarit is potentially useful for the treatment of neuroimmunological disorders, such as multiple sclerosis."
05/01/1998 - "To elucidate the efficacy of 4-acetylaminophenylacetic acid (actarit), an anti-rheumatic drug, on neuroinflammatory diseases such as multiple sclerosis, the effects of actarit on both actively induced and adoptively transferred experimental autoimmune encephalomyelitis (EAE) were studied. "

05/01/1998 - "Suppressive effects of 4-acetylaminophenylacetic acid (actarit) on experimental autoimmune encephalomyelitis in rats."
05/01/1998 - "To elucidate the efficacy of 4-acetylaminophenylacetic acid (actarit), an anti-rheumatic drug, on neuroinflammatory diseases such as multiple sclerosis, the effects of actarit on both actively induced and adoptively transferred experimental autoimmune encephalomyelitis (EAE) were studied. "

05/01/1998 - "To elucidate the efficacy of 4-acetylaminophenylacetic acid (actarit), an anti-rheumatic drug, on neuroinflammatory diseases such as multiple sclerosis, the effects of actarit on both actively induced and adoptively transferred experimental autoimmune encephalomyelitis (EAE) were studied. "